Om P. Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Om P. Sharma has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alimuddin Zumla
Center for Clinical Microbiology, Institute of Infection, Immunity and Transplantation, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK
1 shared publication - Ayana BoydKing
Division of Pulmonary and Critical Care Medicine, Keck School of Medicine, University of Southern California, 1200 North State Street GH 11900, Los Angeles, CA 90033, USA
1 shared publication Carla Lamb
1 shared publication- Kamyar Afshar
University of Southern California, Keck School of Medicine, Division of Pulmonary and Critical Care Medicine, Los Angeles, CA, USA
1 shared publication - Massoud Mahmoudi
University of California San Francisco
1 shared publication
Latest Publications
- 1 November 2011
- Published by SAGE Publications in Journal of Medical Biography
- Vol. 19 (4) , 171-176
Medicine in Dr Samuel Johnson's Dictionary of the English Language
When compiling the Dictionary of the English Language, Johnson read and annotated over two hundred thousand passages from innumerable English authors of various disciplines across four centuries. Most of the literary anecdotes came from Shakespeare, Milton, Dryden and Pope. The medical and scientific anecdotes came from 31 scientists, physicians, pharmacologists and surgeons. This reflects Johnson's admiration for science and its benefit to the public. He told Boswell, ‘Why Sir, if you have but one book with you upon a journey let it be a book of science. When you read through a book of entertainment, you know it, and it can do no more for you, but a book of science is inexhaustible’.
- 1 November 2011
- Published by SAGE Publications in Journal of Medical Biography
- Vol. 19 (4) , 171-176
Medicine in Dr Samuel Johnson's Dictionary of the English Language
When compiling the Dictionary of the English Language, Johnson read and annotated over two hundred thousand passages from innumerable English authors of various disciplines across four centuries. Most of the literary anecdotes came from Shakespeare, Milton, Dryden and Pope. The medical and scientific anecdotes came from 31 scientists, physicians, pharmacologists and surgeons. This reflects Johnson's admiration for science and its benefit to the public. He told Boswell, ‘Why Sir, if you have but one book with you upon a journey let it be a book of science. When you read through a book of entertainment, you know it, and it can do no more for you, but a book of science is inexhaustible’.
- 26 August 2011
- Published by Springer Nature
- p. 253-274
Sarcoidosis
David Geraint James
Devoted his professional life to sarcoidosis In 1958 David Geraint James invited a group of national and international doctors to the Brompton Hospital for a meeting on sarcoidosis. The meeting lasted for three days. This was the first international conference on sarcoidosis; Gerry had sown the seeds of the movement that led to the formation of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) in 1987, in Milan, Italy. Gerry was its founder president. Soon after, with personal financial backing of Gianfranco Rizzato and with Gerry’s persistence, the journal Sarcoidosis became the official voice of WASOG. David Geraint James was born on 2 January 1922 in Treherbert, Rhondda Valley, Wales. His father was a teacher and wrote a regular Welsh column for the national daily the Western Mail . From his father Gerry inherited his love for the Welsh language and Welsh heritage. By the age of 10 he had become an active member of Urdd Gobaith Cymru (Welsh League of Youth) and had developed a command of both Welsh and English. He could …
David Geraint James
Devoted his professional life to sarcoidosis In 1958 David Geraint James invited a group of national and international doctors to the Brompton Hospital for a meeting on sarcoidosis. The meeting lasted for three days. This was the first international conference on sarcoidosis; Gerry had sown the seeds of the movement that led to the formation of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) in 1987, in Milan, Italy. Gerry was its founder president. Soon after, with personal financial backing of Gianfranco Rizzato and with Gerry’s persistence, the journal Sarcoidosis became the official voice of WASOG. David Geraint James was born on 2 January 1922 in Treherbert, Rhondda Valley, Wales. His father was a teacher and wrote a regular Welsh column for the national daily the Western Mail . From his father Gerry inherited his love for the Welsh language and Welsh heritage. By the age of 10 he had become an active member of Urdd Gobaith Cymru (Welsh League of Youth) and had developed a command of both Welsh and English. He could …
- 1 September 2010
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 16 (5) , 487-488
Vitamin D and sarcoidosis
- 1 September 2010
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 16 (5) , 487-488
Vitamin D and sarcoidosis
- Open Access
- 30 September 2008
- Published by PAGEPress Publications
- Vol. 70 (3)
Report from the 9th WASOG Meeting & 11th BAL International Conference
- 30 September 2008
- Published by PAGEPress Publications
- Vol. 70 (3)
Open AccessReport from the 9th WASOG Meeting & 11th BAL International Conference
- Open Access
- 3 September 2008
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 2 (1) , 291
Exudative pleurisy of coccidioidomycosis: A case report and review of the literature
Community-acquired pneumonia is the most common manifestation in primary coccidioides infections (Coccidioides immitis, C. posadasii). It is essential that this endemic dimorphic fungus be considered in order to proceed with the most appropriate diagnostic tools and therapy.
- 3 September 2008
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 2 (1) , 291
Open AccessExudative pleurisy of coccidioidomycosis: A case report and review of the literature
Community-acquired pneumonia is the most common manifestation in primary coccidioides infections (Coccidioides immitis, C. posadasii). It is essential that this endemic dimorphic fungus be considered in order to proceed with the most appropriate diagnostic tools and therapy.
- 1 September 2008
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 29 (3) , 357-363
Sarcoidosis Around the World
- 1 September 2008
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 29 (3) , 357-363
Sarcoidosis Around the World
- 1 May 2007
- Published by Elsevier in Clinics in Dermatology
- Vol. 25 (3) , 232-241
Sarcoidosis: a historical perspective
- 1 May 2007
- Published by Elsevier in Clinics in Dermatology
- Vol. 25 (3) , 232-241
Sarcoidosis: a historical perspective
- 1 March 2006
- Published by Oxford University Press (OUP)
- Vol. 82 (965) , 157-161
Shushaku Endo (1923–1996): his tuberculosis and his writings
Shushaku Endo, one of the finest 20th century Japanese novelists, is not as well known in the West as some of his contemporary Japanese writers including, Yukio Mishima, Yasunari Kawabata, Kobo Abe, and Kenzaburo Oe. Mishima deals with turmoil of adolescence laced with surrealistic historical romance; Abe conjures strange, evocative images in the Kafkaesque tradition; Kawabata writes about loneliness and desolation; and Oe creates imaginary themes of life and myth that entwine and portray human predicaments. Kawabata and Oe both received Nobel Prizes in Literature. Endo's writing is different. He confronts problems pertaining to faith, morality, and individual responsibility. In his early years Endo struggled as a loner, an outsider, and a misfit. This pattern continued to a large extent into his adult life, most of which was consumed with fighting his life threatening tuberculosis. The agonies of his illness intensified his talent for exploring the complexity of human relationships.
- 1 March 2006
- Published by Oxford University Press (OUP)
- Vol. 82 (965) , 157-161
Shushaku Endo (1923–1996): his tuberculosis and his writings
Shushaku Endo, one of the finest 20th century Japanese novelists, is not as well known in the West as some of his contemporary Japanese writers including, Yukio Mishima, Yasunari Kawabata, Kobo Abe, and Kenzaburo Oe. Mishima deals with turmoil of adolescence laced with surrealistic historical romance; Abe conjures strange, evocative images in the Kafkaesque tradition; Kawabata writes about loneliness and desolation; and Oe creates imaginary themes of life and myth that entwine and portray human predicaments. Kawabata and Oe both received Nobel Prizes in Literature. Endo's writing is different. He confronts problems pertaining to faith, morality, and individual responsibility. In his early years Endo struggled as a loner, an outsider, and a misfit. This pattern continued to a large extent into his adult life, most of which was consumed with fighting his life threatening tuberculosis. The agonies of his illness intensified his talent for exploring the complexity of human relationships.
- 1 September 2005
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 11 (5) , 408-411
Paraproteinemias and the lungs
Paraproteinemias are a group of multisystem disorders characterized by neoplastic proliferation of a single clone of immunoglobulin-producing plasma cells. These disorders are amyloidosis, multiple myeloma, Waldenstrom's macroglobulinemia, heavy chain disease, and monoclonal gammopathy of uncertain significance. Amyloidosis is a multisystem disease of unknown cause, characterized by extracellular deposition of amyloid, a complex protein-polysaccharide, in various tissues. Approximately 20 types of fibrils have been found in the amyloid deposits. The disease, depending on the type of amyloid fibril, is divided into two clinical groups. Primary amyloidosis occurs in patients who have no evidence of an underlying cause; the amyloid fibrils consist mainly of immunoglobulin light chains. The heart, tongue, gastrointestinal tract, nerves, and skin are the frequently affected organs in primary amyloidosis. The widespread organ dysfunction results in nephrotic syndrome and renal failure, cardiomyopathy and conduction disturbances, intestinal malabsorption, carpal tunnel syndrome, macroglossia, neuropathy, end-organ insufficiency of endocrine glands, capillary damage, and ecchymosis. Pulmonary involvement is common. It takes the form of diffuse alveolar, septal involvement that manifests on a chest roentgenogram as interstitial infiltrate, nodules in the airways, parenchyma, pleural nodules, and pleural effusion. The prognosis is poor for the patients with primary amyloidosis who have pulmonary involvement [1]. Secondary amyloidosis, by contrast, complicates chronic diseases and is most commonly associated with rheumatoid arthritis, bronchiectasis, osteomyelitis, cystic fibrosis, tuberculosis, leprosy, and sarcoidosis. The fibrils are predominantly AA and are found mainly in the liver, kidney, and spleen. In secondary amyloidosis, pulmonary involvement is rare. Otherwise, no consistent differences between primary and secondary amyloidosis have been demonstrated on the basis of organ distribution [2]. Pulmonary amyloidosis can be classified as follows. The amyloid deposits in the walls of the tracheobronchial tree produce submucosal plaques and endobronchial nodules. On bronchoscopic examination, the submucosal plaques appear as smooth, shiny ridges, often causing bronchial narrowing. Patients with submucosal plaques usually have dyspnea, stridor, or hemoptysis. The endobronchial lesions are polypoid, usually solitary, and occur only in major bronchi; localized tumors of the lower respiratory are uncommon. Male individuals are more commonly affected than female individuals. The lesion may remain asymptomatic and may be discovered only as a circumscribed shadow on a routine chest roentgenogram. Occasionally, patients with bronchial obstruction experience postobstructive pneumonitis, atelectasis, and bronchiectasis. A variant of tracheobronchial amyloidosis, tracheobronchopathica osteoplastica, is characterized by diffuse airway calcification [3]. Parenchymal nodules appear as discrete small opacities, usually in the peripheral lung fields, and are discovered on routine chest radiography. The nodules may vary in size up to 15 cm in diameter. One third of all the nodules cavitate. Calcification, when it occurs, is described as stippled or cloudlike [4,5]. Some of these nodules show increased activity on fluorodeoxyglucose position emission tomography [6]. Diffuse alveolar-interstitial pulmonary involvement is usually associated with systemic amyloidosis. In 1979, Kanada [7] reviewed 12 patients with diffuse interstitial amyloidosis. All patients had dyspnea, and four had a dry cough. The chest roentgenograms showed a diffuse reticulonodular or interstitial pattern. Lung function abnormalities included a restrictive pattern with marked impairment of gas transfer. Diffuse interstitial involvement usually leads to death due to respiratory insufficiency within 6 weeks to 2 years. In parenchymal amyloidosis, high-resolution computed tomography may show perilymphatic nodules mimicking sarcoidosis, military tuberculosis, disseminated histoplasmosis, or coccidioidomycosis [8]. Amyloidosis may cause unilateral or bilateral hilar adenopathy and may mimic sarcoidosis, lymphoma, primary tuberculosis, or coccidioidomycosis. Involvement of pleura is rare in amyloidosis; when it occurs, it is associated with diffuse interstitial lung disease.
- 1 September 2005
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 11 (5) , 408-411
Paraproteinemias and the lungs
Paraproteinemias are a group of multisystem disorders characterized by neoplastic proliferation of a single clone of immunoglobulin-producing plasma cells. These disorders are amyloidosis, multiple myeloma, Waldenstrom's macroglobulinemia, heavy chain disease, and monoclonal gammopathy of uncertain significance. Amyloidosis is a multisystem disease of unknown cause, characterized by extracellular deposition of amyloid, a complex protein-polysaccharide, in various tissues. Approximately 20 types of fibrils have been found in the amyloid deposits. The disease, depending on the type of amyloid fibril, is divided into two clinical groups. Primary amyloidosis occurs in patients who have no evidence of an underlying cause; the amyloid fibrils consist mainly of immunoglobulin light chains. The heart, tongue, gastrointestinal tract, nerves, and skin are the frequently affected organs in primary amyloidosis. The widespread organ dysfunction results in nephrotic syndrome and renal failure, cardiomyopathy and conduction disturbances, intestinal malabsorption, carpal tunnel syndrome, macroglossia, neuropathy, end-organ insufficiency of endocrine glands, capillary damage, and ecchymosis. Pulmonary involvement is common. It takes the form of diffuse alveolar, septal involvement that manifests on a chest roentgenogram as interstitial infiltrate, nodules in the airways, parenchyma, pleural nodules, and pleural effusion. The prognosis is poor for the patients with primary amyloidosis who have pulmonary involvement [1]. Secondary amyloidosis, by contrast, complicates chronic diseases and is most commonly associated with rheumatoid arthritis, bronchiectasis, osteomyelitis, cystic fibrosis, tuberculosis, leprosy, and sarcoidosis. The fibrils are predominantly AA and are found mainly in the liver, kidney, and spleen. In secondary amyloidosis, pulmonary involvement is rare. Otherwise, no consistent differences between primary and secondary amyloidosis have been demonstrated on the basis of organ distribution [2]. Pulmonary amyloidosis can be classified as follows. The amyloid deposits in the walls of the tracheobronchial tree produce submucosal plaques and endobronchial nodules. On bronchoscopic examination, the submucosal plaques appear as smooth, shiny ridges, often causing bronchial narrowing. Patients with submucosal plaques usually have dyspnea, stridor, or hemoptysis. The endobronchial lesions are polypoid, usually solitary, and occur only in major bronchi; localized tumors of the lower respiratory are uncommon. Male individuals are more commonly affected than female individuals. The lesion may remain asymptomatic and may be discovered only as a circumscribed shadow on a routine chest roentgenogram. Occasionally, patients with bronchial obstruction experience postobstructive pneumonitis, atelectasis, and bronchiectasis. A variant of tracheobronchial amyloidosis, tracheobronchopathica osteoplastica, is characterized by diffuse airway calcification [3]. Parenchymal nodules appear as discrete small opacities, usually in the peripheral lung fields, and are discovered on routine chest radiography. The nodules may vary in size up to 15 cm in diameter. One third of all the nodules cavitate. Calcification, when it occurs, is described as stippled or cloudlike [4,5]. Some of these nodules show increased activity on fluorodeoxyglucose position emission tomography [6]. Diffuse alveolar-interstitial pulmonary involvement is usually associated with systemic amyloidosis. In 1979, Kanada [7] reviewed 12 patients with diffuse interstitial amyloidosis. All patients had dyspnea, and four had a dry cough. The chest roentgenograms showed a diffuse reticulonodular or interstitial pattern. Lung function abnormalities included a restrictive pattern with marked impairment of gas transfer. Diffuse interstitial involvement usually leads to death due to respiratory insufficiency within 6 weeks to 2 years. In parenchymal amyloidosis, high-resolution computed tomography may show perilymphatic nodules mimicking sarcoidosis, military tuberculosis, disseminated histoplasmosis, or coccidioidomycosis [8]. Amyloidosis may cause unilateral or bilateral hilar adenopathy and may mimic sarcoidosis, lymphoma, primary tuberculosis, or coccidioidomycosis. Involvement of pleura is rare in amyloidosis; when it occurs, it is associated with diffuse interstitial lung disease.